Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study.

Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study. Cancer. 1988 Dec 01; 62(11):2309-12.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.